02225 JINHAI MED TECH
- 4.840
- +0.020+0.41%
JINHAI MED TECH News
Jinhai Medical Technology Swings to Loss in 2023
Jinhai Medical Technology (HKG:2225) reported a loss attributable to the owners of SG$3.1 million for the year ended Dec. 31, 2023, compared with a profit of about SG$468,000 in the previous year, acc
今海醫療科技：二零二三年年報
Jinhai Medical Technology (02225.HK) acquired Neuhaus Engineering Pte. Ltd. 100% equity
Jinhai Medical Technology (02225.HK) announced that on October 20, 2023, Nichefield, an indirect wholly-owned subsidiary of the company (as a buyer), acquired the target company Neuhaus Engineering Pte from these sellers. 100% interest in Ltd.
Jinhai Medical Technology (02225.HK) subsidiary plans to acquire a property for SGD 10.18 million
Jinhai Medical Technology (02225.HK) announced that on May 17, 2023, the buyer KT&T Engineers and Constructors Pte. Ltd. (a wholly-owned subsidiary of the company) entered into a purchase agreement with the seller Eng Lee Engineering Pte Ltd., which involved the buyer to acquire the property at a total cost of SGD 10.18 million (excluding goods and services tax payable).
Jinhai Medical Technology (02225.HK): Zheng Yuan was appointed as company secretary
Gelonghui, April 2, 丨 Jinhai Medical Technology (02225.HK) announced that Zheng Yuan has been appointed as company secretary, effective April 2, 2024.
Jinhai Medical Technology (02225.HK): Net loss of SGD 3.141,000 in 2023
On March 28, GLONGHUI | Jinhai Medical Technology (02225.HK) announced that for the year ended December 31, 2023, revenue was approximately SGD 45.644,000, up about 105% year on year; loss attributable to company owners was approximately SGD 3.141 million, profit attributable to company owners was approximately SGD 468,000; basic loss per share was SGD 0.25.
JINHAI MED TECH: Announcement of Annual Results for the Year Ended 31 December 2023
Jinhai Medical Technology (02225.HK) Profit Alert: Expected annual net loss of 3.5 million to 4.5 million Singapore dollars
On March 22, GLONGHUI | Jinhai Medical Technology (02225.HK) announced that the company expects to record a net loss of SGD 3.5 million to SGD 4.5 million for the year ending December 31, 2023, compared with net profit of SGD 0.12 million for the previous year. The expected shift from net profit to net loss is mainly due to the following reasons: 1. After the board of directors previously re-evaluated its business priorities and strategic direction, the Group actively developed minimally invasive surgery solutions and related medical products and services in China. As a result, there were a number of early product development and test manufacturing costs. During the reporting period there were
今海醫療科技：盈利警告
Jinhai Medical Technology (02225.HK) plans to hold a board meeting on March 27 to approve annual results
Glonghui March 15 | Jinhai Medical Technology (02225.HK) announced that it will hold a board meeting on March 27, 2024 to consider and approve (including) the announcement of the company's and its subsidiaries' annual results for the year ended 31 December 2023 and the payment of a final dividend (if applicable).
JINHAI MED TECH: Date of Board Meeting
Jinhai Medical Technology (02225): Chen Guobao has been appointed as authorized representative
Jinhai Medical Technology (02225) issued an announcement that Shi Junbai has resigned as the company secretary; and according to Hong Kong law, China...
Jinhai Medical Technology (02225.HK): Shi Junbai resigns as company secretary
Gelonghui March 14 | Jinhai Medical Technology (02225.HK) issued an announcement. Shi Junbai has resigned as company secretary and authorized representative of the company, effective March 14, 2024. Chairman of the Board and Executive Director Chen Guobao has been appointed as an authorized representative under the Listing Rules, while Hong Jingjing, an employee of the Group, has been appointed as an authorized representative under the Hong Kong Companies Ordinance to replace Ms. Shi, effective from March 14, 2024.
Jinhai International Group Renamed As Jinhai Medical Technology
Jinhai International Group Holdings (HKG:2225) has changed its English name to 'Jinhai Medical Technology Limited', according to a Friday filing. The English short stock name on the Hong Kong bourse w
Jinhai International (02225) stock abbreviation changed to “Jinhai Medical Technology”
Zhitong Finance App News, Jinhai International (02225) issued an announcement. After passing a special resolution at the special shareholders' meeting held on December 20, 2023, the Registrar of Companies of the Cayman Islands issued a company registration certificate to change the name on December 28, 2023, certifying that the company's English name was changed from “Jinhai International Group Holdings Limited” to “Jinhai Medical Technology Limited” and that the company was changed The dual foreign name is “Imami
Jinhai International (02225.HK) granted a total of 129 million share options
Gelonghui, January 9, 丨 Jinhai International (02225.HK) announced that on January 9, 2024, the board of directors (in addition to Wang abandoning the vote on the grant of the share option) decided to grant the grantor a total of 129 million share options under the terms of the share option plan. Of these, 71,087,500 share options were conditionally granted to Liu, 6,462,500 share options were granted to Wang, and 51,700,000 share options were granted to nine other full-time employees of the Group, subject to acceptance or rejection. Conditional grants are subject to shareholders' approval at a special shareholders' meeting.
Jinhai International (02225.HK): Liu Lei was appointed as Group Chief Scientific Officer
Gelonghui, January 8, 丨 Jinhai International (02225.HK) announced that Liu Lei (director and general manager of Shanghai Jinhai Medical Technology Co., Ltd., an indirect wholly-owned subsidiary of the company) was appointed as the Group's Chief Scientific Officer, effective from December 1, 2023. The initial term is three years. He is mainly responsible for obtaining certificates and research and development for Jinhai Medical's products, and supervising the implementation of other new products and technologies to ensure that they will meet the Group's long-term development strategy.
Jinhai International (02225): Shi Junbai was appointed as company secretary
Jinhai International (02225) announced that Wong Man-yiu has resigned (i) as company secretary, and (ii) according to the Hong Kong Federation...
Jinhai International Group Proposes Stock Awards to Staffers, Service Providers
Jinhai International Group Holdings (HKG:2225) proposes to allot over 129.2 million shares, representing 10% of the firm's issued capital, to its employees and service providers, to incentivize their
Jinhai International (02225.HK) Proposes Adoption of a Share Option Plan
Gelonghui, December 4, Jinhai International (02225.HK) announced that the board of directors has decided to recommend the adoption of a share option plan for shareholders to approve at the special shareholders' meeting. A share option plan is a share plan prepared in accordance with Chapter 17 of the listing rules. The purpose of the share option scheme is to (i) provide eligible participants with an opportunity to obtain ownership interests in the company and encourage eligible participants to strive to enhance the value of the company and its shares to benefit the overall interests of the company and its shareholders; (ii) motivate eligible participants to contribute to the success of the Group's business; and (iii) provide the company with flexible ways to retain, motivate and reward
Analysis
Price Target
No Data
